[Use of lipostabil to correct lipid metabolism disorders in patients with ischemic heart disease].
A comparative study of biochemical and immunologic patterns showed lipostabil treatment to be effective in less than half of the patients with unstable angina. A method is developed for in vitro testing of individual blood mononuclear sensitivity to lipostabil effects. The proposed set of biochemical and immune assays allows the selection of patients subject to lipostabil treatment and provides additional criteria for the assessment of its efficiency.
V A
VA
Almazov
I S
IS
Freĭdlin
E I
EI
Krasil'nikova
D000328:Adult; D000787:Angina Pectoris / Q000188:drug therapy*; D000789:Angina, Unstable / Q000097:blood / Q000188:drug therapy*; D002784:Cholesterol / Q000097:blood; D006801:Humans; D066298:In Vitro Techniques; D007958:Leukocyte Count; D007962:Leukocytes / Q000187:drug effects; D008074:Lipoproteins / Q000097:blood; D008297:Male; D008875:Middle Aged; D009113:Muramidase / Q000097:blood; D010713:Phosphatidylcholines / Q000494:pharmacology / Q000627:therapeutic use*
D008074:Lipoproteins; D010713:Phosphatidylcholines; C005152:lipostabil; D002784:Cholesterol; D009113:Muramidase
Primenenie lipostabila dlia korrektsii narusheniĭ lipidnogo obmena u bol'nykh ishemicheskoĭ bolezn'iu serdts.